The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately.
SonoSite’s NanoMaxx Enters U.S.
The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately. International deliveries began in June. Featuring one-button optimization technology, the six pound NanoMaxx system will be marketed as a point-of-care system to hospitals and physician offices. The system, which boots up in less than 20 seconds, comes with five transducers to support thoracic assessment for pathology, vascular access, and needle aspirations and injections, as well as abdominal, cardiac, nerve, OB/Gyn, musculoskeletal, small parts and vascular scanning. NanoMaxx can be wall mounted, placed on an exam table with kickstand attached, used from a floor-based stand, or hand carried.
What New Research Reveals About Novice Use of AI-Guided Cardiac Ultrasound
April 4th 2025In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.